chrisvoncsefalvay/vaers-outcomes huggingface dataset:
contracted COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (contracted COVID-19) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In July 2021, the patient experienced COVID-19 (contracted COVID-19). At the time of the report, COVID-19 (contracted COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In July 2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment medications were reported.  It was reported that patient contracted COVID-19 in the middle on 24 Jul 2 021 or 25 Jul 2021.
I have not had a period and am 8 days late. Waves of nausea daily.
Patient developed inconsolable crying for 2-3 hours and could not be put down despite Tylenol.
The patient received a 2nd booster 4th immunization for Covid 19 vaccine. Moderna Lot# 059A22A exp 6/30/22 . They were not elgible . They were 42 years old
This spontaneous report was received from a registered nurse. The nurse stated that on 01-APR-2014 (reported as yesterday) that a few patients was vaccinated with PROQUAD, subcutaneously and VARIVAX, subcutaneously which were improperly stored. No adverse events were reported. Additional information is not expected.
Within 5-10 minutes she developed a large swelling to the injection site and it became red, hot, and painful.
Patient called and stated that she has an adverse reaction to a flu vaccine she received a few days ago at our pharmacy. She is reporting increasing amount of pain (severe) in her arm that started the night of her vaccine administration date, 9/22/21-about 5 hours after she received it. She is describing pain as burning, shooting, and throbbing that shoots through her arm toward her fingers and then she experiences some tingling sensation. Pain is felt at the front of the right shoulder which is the same arm in which vaccine was administered.
Red, swollen, and hot and injection site. Not going away. Sore neck, had a hard knot but that went away. Extreme itching at injection site
Had Moderna vaccine dose 1 on 2/18/21. 1 week later on 2/25 she stated her injection site had redness, swelling and was feverish. Injection site redness has spread out about 6 inches but is improving now on 3/2/21.
I had arm pain on the day of vaccination. A week later, I had a tension/migraine headache with pretty severe pain at the base of my skull, more left side than right side and at the top with nausea that lasted for a solid 5 days.  My BP and vitals were fine. It was just this constant head pain.
Fever, inability to stand/ambulate, severe body pain (generalized), inability to eat, chills, sweats, dizziness, pain in left upper arm with edema,  x 48 hours, hot burning urination, stayed on couch with oxygen at 2 l nc, hydrated with fluids, tylenol and/or hyrdocodone/acetamephone prn for fever/fever/pain unreleaved by tylenol. Ambulate with assist to bathroom and back, used a walker, felt like I was going to die, unable to preform any adls including going for medical care.
Arm where shot given is red and hot and achy.  Much worse than when I received the vaccine.
Fatigue.  Scars on toes, fingers, and forehead.  Shortness of breathe. Shortness of breathe got progressively worse. Contracted Covid 19 in December. Shortness of breathe got significantly worse.
7/11 - arm (upper) was reported as red and swollen. Rx BENADRYL and warm compresses. 7/12 - redness spread to wrist but swelling decreased and tenderness. 7/13 - seen in office. Redness from deltoid - wrist. Minimal swelling. Rx - PREDNISONE 1 pl BID x 4d.
sudden onset fever, chill, coryza, nausea, scratching throat, coughing
Severe pain in arm at injection site began about 12 hours after the vaccine was administered. Redness, swelling, itching, pain to the touch began the next day. Three days have passed and the pain, redness and swelling have not subsided.
HYPERtension Narrative: Elevated BP with no response, had to change BP medication.
pt recvd vax; hard bump, started as blotchy rash w/in a few days; 5-6" diam; also redness behind knees;
Information has been received from nurse practitioner concerning a healthy 7 year old male student with no allergies and no past medical history who on 03Nov98  was vaccinated with a dose of varicella virus vaccine live. Concomitant vaccination on 03Nov99 included a dose of Hib conj vaccine and a dose of diphtheria toxoid (+) pertussis acellular Biken vaccine (+) tetanus toxoid. On 16Oct03, the pt developed varicella. The pt presented to the medical office with a history of fever and more than 100 vesicular lesions on his back, chest, face and 4 to 6 in his mouth. The pt was treated with diphenhydramine hydrochloride (Benadryl Elixir), calamine lotion and acetaminophen (Tylenol). The pt had a varicella titer during the week and the results were pending. Subsequently, the pt recovered. The reporter noted that the pt's two sisters had not experienced symptoms. A product quality complaint was not involved. The reporter also mentioned that the pt's two brothers developed varicella post vaccination with varicella virus vaccine live. Additional information is not expected.
Left shoulder pain - was seen by physician in physical rehab department. Recommended TYLENOL dosing and MRI. Dx probable bursitis due to injection. Elected to delay MRI, hoping symptoms would improve.
report recvd from pt's father who indicated that pt recvd vax & died the next day; COD: SIDS;  parent has been transferred to Korea; no addtl details are available;
Developed Fever and chills during the night 4/8/2021.  Felt fatigued with intermittent chills on 4/9/2021 and then fever and chills again that night. Felt fine Saturday 4/10 and then Sunday 4/11 developed low grade chest pain lasting 2 hours and resolved with Advil.  Awakened at 5am on Monday 4/12 with severe diffuse chest pain requiring hospitalization and treated for myopericarditis.
Tongue Swelling, chest tightness, shortness of breath, tachycardia
Redness and itchiness on inside of right hand, near wrist, opposite side of thumb; Redness and itchiness on inside of right hand, near wrist, opposite side of thumb; This is a spontaneous report from a non-contactable consumer (patient). A 68-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; lot number: EL9266), via an unspecified route of administration, administered in the left arm on 22Feb2021 10:00 (at the age of 68-years-old) as dose 1, single for COVID-19 immunization. Medical history included sulfa allergy. Prior to vaccination, the patient did not have COVID-19. Concomitant medications included bupropion, levothyroxine (LEVOTHYROXINE), and pitavastatin magnesium (ZYPITAMAG). The patient did not receive any other vaccine within 4 weeks of the COVID vaccination. On 22Feb2021 15:15, the patient experienced redness and itchiness on inside of right hand, near wrist, opposite side of thumb which lasted for one hour. Therapeutic measures were not taken as result of the events. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the event was recovered on 22Feb2021 16:15.  No follow-up attempts are possible. No further information is expected.
Noticed itchy, bumpy rash on face, and red patches and itchiness on hands.  Next morning (9/28/2011), rash had developed fully on entire face, including forehead and nose; rash around site of injection.  Took Benadryl overnight, but next day (9/29/2011), rash still there.
Patient received dose 1 of Pfizer Covid19 mRNA vaccine. Name and date of birth on check in slip were making the patient 12 years of age. When charting  dose given, records indicated that patient was in fact 11 years 11 months and 16 days of age. Called the mother and she verified that he will be 12 in 2 weeks and wanted patient to get the vaccine before school started. Mother stated patient had an episode of diarrhea 8/3/2021 in the evening but has recovered from this.  Dose 2 of the series is scheduled for after patient turns 12 years of age.
Hemifacial Spasms on left side, lip eye, forehead, nose area. Began 40 minutes after receiving vaccine. Has been almost 24 hours and no relief.
I had a bad reaction to my first dose of this shot (a separate  report has been filed on that) that caused a severe flare up of long dormant Lupus symptoms.  On day one after the 2nd shot I got light headed and had tingling in my arms and legs.  On day 3 after the shot I developed chest pain and shortness of breath along with light headedness.  On day 6 I developed severe stomach pain in addition to other symptoms.  I thought it was all from the shot so kept waiting thinking I was ok and it would get better.  By day 7 I had severe chest pain and shortness of breath and severe stomach pain that made me think I was having a heart attack or had a blood clot in my lungs.  I went to the Emergency Room at this point.  The doctors ruled out heart attack and blood clot via blood tests and CT scan.  They also did a Covid test which was Negative. They sent me home after 6 hours of testing with no explanation of what was wrong with me.  The next day I did a follow up visit with an Internist who did more blood work and told me the symptoms I was having was from a reaction to the vaccine.  That the vaccine causes inflammation and that it went after my weak and already inflamed areas such as lungs from Asthma, and stomach from Reflux GERD.  My ANA also had remained elevated since a reaction to the first shot.
Missed third and fourth dose; Spontaneous report received on 27FEB2020.  A nurse reported that a consumer "missed third and fourth dose" (PT: Product dose omission) while being on Vivotif for immunisation. Onan unknown date, the consumer took fisrt and second dose of Vivotif. However, the consumer missed the third and fourth dose of Vivotif. Action taken with Vivotif with respect to the reported event was not applicable. The outcome of the reported event was unknown.  Company Comment: A consumer took first two doses of Vivotif and then missed the third and fourth dose (missed dose). Vivotif should be taken every other day. Considering the nature of the event, the causality of missed dose is assessed as not applicable to Vivotif.; Sender's Comments: A consumer took first two doses of Vivotif and then missed the third and fourth dose (missed dose). Vivotif should be taken every other day. Considering the nature of the event, the causality of missed dose is assessed as not applicable to Vivotif.
Patient has since had a splenectomy after 2 Shingrix doses; This non-serious case was reported by a other health professional via sales rep and described the occurrence of splenectomy in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (on an unknown date received 1st dose).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced splenectomy (Verbatim: splenectomy).  The outcome of the splenectomy was unknown.   It was unknown if the reporter considered the splenectomy to be related to Shingrix.     It was unknown if the company considered the splenectomy to be related to Shingrix.   Additional Information: GSK receipt date: 07-SEP-2023 Medical information department received The patient received both doses of Shingrix.  The patient since had a splenectomy. The reporter was  wondering if the patient should receive an additional dose (or doses) to provide post-splenectomy protection against shingles. The reporter consented to follow up.
Information has been received from a health care worker who reported that one of their patient's mother stated that her niece, on an unknown date was vaccinated with the third dose of GARDASIL. The health care worker reported that the patient didn't go to their office. The patient's aunt reported that her niece shortly after received her third dose of GARDASIL  had a seizure. The patient's aunt reported that the seizure happened different times of day and they still happening. She also reported that the patient did see her physician who said that the seizures could be due to GARDASIL. At the time of the report the patient had not recovered. Upon internal review seizure is considered to be an other important medical event. Additional information has been requested.
Injection site soreness; fever; chills; headache; weakness; This is a spontaneous report from a contactable consumer (patient self). A 21-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EN6201, expiration date: unknown), via an unspecified route of administration (location: Left arm) on 26Feb2021 13:00 at age of 21-year-old at single dose for COVID-19 immunization. Medical history included depression, anxiety, obesity, liver disease, avoidant/ restrictive food intake disorder (ARFID). The patient was in the hospital with COVID in April2020. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. No known allergies. Facility where the most recent COVID-19 vaccine was administered was doctor's office/ urgent care. Concomitant medication included fluoxetine hydrochloride (PROZAC), metformin and melatonin. The patient experienced injection site soreness, fever, chills, headache and weakness, all on 27Feb2021 04:00 AM. The patient received acetaminophen (TYLENOL) as treatment. No seriousness criteria was reported: no results in death, no life threatening, no caused/prolonged hospitalization, no disabling/Incapacitating, no congenital anomaly/birth defect. Since the vaccination, the patient hadn't been tested for COVID-19. The outcome of events was recovering.
Hardness; Warm to touch; Redness on top and underneath her arm the size of grapefruit; Itching at the injection site; Soreness from the elbow to shoulder; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION, VACCINATION SITE WARMTH, ERYTHEMA (Redness on top and underneath her arm the size of grapefruit), INJECTION SITE PRURITUS (Itching) and ARTHRALGIA (Soreness from the elbow to shoulder) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced VACCINATION SITE INDURATION, VACCINATION SITE WARMTH, ERYTHEMA (Redness on top and underneath her arm the size of grapefruit), INJECTION SITE PRURITUS (Itching), and ARTHRALGIA (Soreness from the elbow to shoulder). At the time of the report, VACCINATION SITE INDURATION, VACCINATION SITE WARMTH, ERYTHEMA (Redness on top and underneath her arm the size of grapefruit), INJECTION SITE PRURITUS (Itching) and ARTHRALGIA (Soreness from the elbow to shoulder) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
MAGNETIC CHARACTERISTICS/MADE MAGNETIC; This spontaneous report received from a patient via a company representative concerned an adult female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 08-OCT-2021, the patient experienced magnetic characteristics/made magnetic. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of magnetic characteristics/made magnetic was not reported. This report was non-serious.
Severe pain at injection site, huge knot and redness still today on day 3. Tired, nausea, stomach ache, severe headache, muscle aches.  Generally feeling unwell and low grade fever.
Information was received from a lawyer regarding a case in litigation involving a male patient, age and medical history not provided. In 2013 the patient was inoculated with ZOSTAVAX vaccine at a medical clinic for routine adult health maintenance and the prevention of shingles. The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster. In 2014 the patient was treated by a physician at internal medicine clinic for a severe vesicular rash which was diagnosed as herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX or despite receiving ZOSTAVAX for prevention of shingles, the patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain, suffering and other damages. Additional information has been requested.
patient received a dose of Menveo reconstituted with sterile water; patient received a dose of Menveo reconstituted with sterile water; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 14-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA721A) for prophylaxis.   On 08-AUG-2023, the patient received Menveo. On 08-AUG-2023, an unknown time after receiving Menveo, the patient experienced wrong solution used in drug reconstitution (Verbatim: patient received a dose of Menveo reconstituted with sterile water) and inappropriate dose of vaccine administered (Verbatim: patient received a dose of Menveo reconstituted with sterile water). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt date: 09-AUG-2023 A nurse reported that a patient received a dose of Menveo reconstituted with sterile water and wanted to know how to proceed. The patient received Menveo reconstituted with sterile water which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up.
depression; I felt lousy/It was annoying; I got Covid after my 2nd Moderna booster, around 15Aug2022.I had a lot of coughing, I was tired a lot; This spontaneous case was reported by a patient and describes the occurrence of DEPRESSION (depression), COVID-19 (I got Covid after my 2nd Moderna booster, around 15Aug2022.I had a lot of coughing, I was tired a lot) and FEELING ABNORMAL (I felt lousy/It was annoying) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.    In August 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In August 2022, the patient experienced COVID-19 (I got Covid after my 2nd Moderna booster, around 15Aug2022.I had a lot of coughing, I was tired a lot). On an unknown date, the patient experienced DEPRESSION (depression) and FEELING ABNORMAL (I felt lousy/It was annoying). At the time of the report, DEPRESSION (depression) had resolved and COVID-19 (I got Covid after my 2nd Moderna booster, around 15Aug2022.I had a lot of coughing, I was tired a lot) and FEELING ABNORMAL (I felt lousy/It was annoying) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication details not reported by the reporter. Treatment details was not reported by the reporter.
A rash appeared on 12/18/01 and also possible conjunctivitis as per pt's mother. Rash seems to be spreading. On 12/19/01, the pt presented to office with generalized varicella lesions, red in each eye and a red pharynx at the time of the exam.
Sore for a day or two but has been really sick with fever, achy and flushed for 5-7 days, started a week after vaccination. Going to PCP.
I95.9 HYPOTENSION 7/18/2022 ELEVATED TRANSAMINASE I95.9 HYPOTENSION 7/18/2022 HEPATIC ENCEPHALOPATHY I95.9 HYPOTENSION 7/18/2022 ELEVATED TRANSAMINASE I95.9 HYPOTENSION 7/18/2022 ELEVATED TRANSAMINASE
Developed urticaria that will come and go over my body from my head, neck, chest, back, arms, hands, legs, and feet spontaneously and itches incessantly until I take a diphenhydramine which covers the issue for 2-3 hours until it returns. It seems to be come when I am warm, sweaty, or otherwise under stress. It still continues to this day from the first appearance.
I am a healthy 43-year old male.  My resting heart rate was at 56-58 beats per minute prior to taking the first COVID vaccine.  The day after taking the J&J vaccine, I began experiencing fast heart palpitations that I continue experiencing today.  I have never felt reoccurring heart palpitations prior to receiving the vaccine.    I also took a Moderna Booster (059M21A) on 6/7/22 and experienced a high level of pain from my waist down to both legs for most of the day on 6/8/22.  The pain was gone by 6/9/22.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age and gender. On unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 lot number was reported as "K007264" with exp. "02-MAR-2017", (dose and route were not provided). No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient states she had chills, HA, sore left arm later that night. The next day, she fell after using the restroom. Couldn't get up and was down for about 3 hours, crawled to her bed.
COLD; some running nose; cough; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (COLD), RHINORRHOEA (some running nose) and COUGH (cough) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypothyroidism and Hypertension. Concomitant products included LISINOPRIL, LEVOTHYROXINE, HYDROCHLOROTHIAZIDE, METOPROLOL and FUROSEMIDE for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced NASOPHARYNGITIS (COLD), RHINORRHOEA (some running nose) and COUGH (cough). At the time of the report, NASOPHARYNGITIS (COLD), RHINORRHOEA (some running nose) and COUGH (cough) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment received for the event is cough syrup